Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study
Graff, Gavin R., MD, Maguiness, Karen, MS, RD, CSP, McNamara, John, MD, Morton, Ronald, MD, Boyd, David, PharmD, Beckmann, Katrin, MSc, Bennett, Djenane, BSN
Published in Clinical therapeutics (2010)
Published in Clinical therapeutics (2010)
Get full text
Journal Article